Back to search

Article

Human MutLα activates methylpurine DNA glycosylase to induce alkylation damage cytotoxicity

2025-12-17

Abstract excerpt

<h4>SUMMARY</h4> Alkylation chemotherapy is commonly used against tumors such as glioblastoma, yet resistance often develops through downregulation of mismatch repair (MMR). Previous work has established that loss of MMR prevents the excision of the thymine-containing strand across O 6 meG-T mismatches. Thus, MMR dysfunction is advantageous because it prevents a vicious cycle of attempted repair that leads to ce...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
927f3df4-dbf9-5dbb-bba5-1ca84703ad3d
DOI
10.64898/2025.12.15.694403
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Human MutLα activates methylpurine DNA glycosylase to induce alkylation damage cytotoxicityDOI 10.64898/2025.12.15.694403
Select a neighboring publication to make it the new centre.